Thomas A. West
Net Worth

Last updated:

What is Thomas A. West net worth?

The estimated net worth of Mr. Thomas A. West is at least $11,234,624 as of 17 Mar 2020. He owns shares worth $6,689,774 as insider and has received compensation worth at least $4,544,850 in Intersect ENT, Inc..

What is the salary of Thomas A. West?

Mr. Thomas A. West salary is $908,970 per year as Pres, Chief Executive Officer & Director in Intersect ENT, Inc..

How old is Thomas A. West?

Mr. Thomas A. West is 61 years old, born in 1964.

What stocks does Thomas A. West currently own?

As insider, Mr. Thomas A. West owns shares in one company:

Company Title Shares Price per share Total value
Intersect ENT, Inc. (XENT) Pres, Chief Executive Officer & Director 236,890 $28.24 $6,689,774

What does Intersect ENT, Inc. do?

Intersect ENT, Inc. operates as an ear, nose, and throat (ENT) medical technology company in the United States. The company offers PROPEL, a steroid releasing implant to open the surgically enlarged sinus; PROPEL Mini, a releasing implant to treat patients undergoing frontal sinus surgery; and PROPEL Contour, a steroid releasing implant for the treatment of frontal and maxillary sinus ostia, or openings, of the dependent sinuses. It also provides SINUVA, a steroid releasing implant for the treatment of patients in the physician office setting; VENSURE Navigable and Stand-alone balloon, a sterile and single-use device, used to access and treat frontal, sphenoid sinus, and maxillary ostia in adults using a trans-nasal approach; and CUBE Navigation System, a virtual guidance platform for high precision ENT and ENT related skull-base surgeries. The company was formerly known as Sinexus, Inc. and changed its name to Intersect ENT, Inc. in November 2009. Intersect ENT, Inc. was incorporated in 2003 and is headquartered in Menlo Park, California.

Thomas A. West insider trading

Intersect ENT, Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 19,035 N/A N/A

Intersect ENT key executives

Intersect ENT, Inc. executives and other stock owners filed with the SEC: